Please login to the form below

Not currently logged in
Email:
Password:

genital herpes

This page shows the latest genital herpes news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II. Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus. ... A vaccine that could free patients with genital herpes from lifelong drug treatment to control outbreaks

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    Vical's genital herpes vaccine flunks trial. The drug did however reduce the emergence of genital lesions in some patients. ... to reduce virus shedding in patients with genital herpes in the phase I/II trial.

  • Sanofi to work with Immune Design on herpes vaccine Sanofi to work with Immune Design on herpes vaccine

    Sanofi has joined forces with US biotech Immune Design to accelerate development of the first therapeutic vaccine against genital herpes. ... Sanofi notes that genital herpes is the most common STI and affects around one in six people in the US, with

  • Trial confirms lack of efficacy for GSK’s herpes vaccine Simplirix

    GlaxoSmithKline's (GSK) herpes vaccine Simplirix has failed to show any efficacy against herpes simplex virus type 2 (HSV-2) as a cause of genital herpes disease. ... The study involved 8, 323 women aged 18 to 30, testing vaccine doses at zero, one and

  • Medivir and Meda in Xerese renegotiation

    Medivir has renegotiated the terms of its financial arrangement with Meda for Xerese, its marketed product for herpes labialis, in North America. ... The agreement also provides Meda with the exclusive US rights to Xerese for the genital herpes indication

  • FDA cracks down on bogus STD drugs

    The two federal agencies are targeting products that make unproven claims to treat, cure, and prevent STDs including herpes, chlamydia, genital warts, HIV and AIDS. ... and proven herpes killers in a single formula"; and Viruxo, which is sold on a

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics